Metraipolis › archive › dc_ede1f2dbae3e

Tocilizumab as a treatment tool for ROSAH syndrome: a case report — Europe PMC PMID:41269507

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41269507
DOI
10.1186/s12348-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-08T08:45:36.415Z
SHA-256 of the archived text
9034eefb0ad7b498ee654743a12ad0b036140e83861c5916984e3c34c26bc9b2
Stable URL of this page
https://metraipolis.com/documento/dc_ede1f2dbae3e

How to cite

Tocilizumab as a treatment tool for ROSAH syndrome: a case report — Europe PMC PMID:41269507 — Europe PMC (en), https://europepmc.org/article/MED/41269507 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ede1f2dbae3e (Metraipolis archive dc_ede1f2dbae3e, sha256 9034eefb0ad7b498ee654743a12ad0b036140e83861c5916984e3c34c26bc9b2)
BibTeX
@misc{dcede1f2dbae3e,
  title = {Tocilizumab as a treatment tool for ROSAH syndrome: a case report — Europe PMC PMID:41269507},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41269507},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ede1f2dbae3e; sha256 9034eefb0ad7b498ee654743a12ad0b036140e83861c5916984e3c34c26bc9b2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41269507. Agents can read the archived copy with the MCP tool read_document.